Pustular psoriasis
Information
- Disease name
- Pustular psoriasis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05215561 | Active, not recruiting | Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP | February 14, 2022 | September 30, 2024 | |
| NCT01794117 | Completed | Phase 2 | Anakinra for Inflammatory Pustular Skin Diseases | July 22, 2013 | October 7, 2019 |
| NCT02343744 | Completed | Phase 3 | An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis | January 19, 2015 | November 2, 2018 |
| NCT03885089 | Completed | Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis) | October 21, 2019 | March 8, 2024 | |
| NCT01952275 | Unknown status | Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases | January 2014 | January 2020 |
- MedGen concept unique identifier (MedGen Concept name)
- C0152081
- MedGen unique identifier (MedGen Concept name)
- 508876